Echeverry-Guerrero, S.; González-Vélez, S.; Arévalo-Lara, A.-S.; Calvache-Orozco, J.-C.; Villarroel-Hagemann, S.K.; Rojas-RodrÃguez, L.C.; Pérez-Acosta, A.M.; Calderon-Ospina, C.-A.
The Inappropriate Use of GLP-1 Analogs: Reflections from Pharmacoepidemiology. Pharmacoepidemiology 2024, 3, 365-372.
https://doi.org/10.3390/pharma3040025
AMA Style
Echeverry-Guerrero S, González-Vélez S, Arévalo-Lara A-S, Calvache-Orozco J-C, Villarroel-Hagemann SK, Rojas-RodrÃguez LC, Pérez-Acosta AM, Calderon-Ospina C-A.
The Inappropriate Use of GLP-1 Analogs: Reflections from Pharmacoepidemiology. Pharmacoepidemiology. 2024; 3(4):365-372.
https://doi.org/10.3390/pharma3040025
Chicago/Turabian Style
Echeverry-Guerrero, SofÃa, Salomé González-Vélez, Ana-SofÃa Arévalo-Lara, Juan-Camilo Calvache-Orozco, Sebastián Kurt Villarroel-Hagemann, Luis Carlos Rojas-RodrÃguez, Andrés M. Pérez-Acosta, and Carlos-Alberto Calderon-Ospina.
2024. "The Inappropriate Use of GLP-1 Analogs: Reflections from Pharmacoepidemiology" Pharmacoepidemiology 3, no. 4: 365-372.
https://doi.org/10.3390/pharma3040025
APA Style
Echeverry-Guerrero, S., González-Vélez, S., Arévalo-Lara, A.-S., Calvache-Orozco, J.-C., Villarroel-Hagemann, S. K., Rojas-RodrÃguez, L. C., Pérez-Acosta, A. M., & Calderon-Ospina, C.-A.
(2024). The Inappropriate Use of GLP-1 Analogs: Reflections from Pharmacoepidemiology. Pharmacoepidemiology, 3(4), 365-372.
https://doi.org/10.3390/pharma3040025
